Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pharmaust Limited ( (AU:NUZ) ) just unveiled an announcement.
Neurizon Therapeutics Limited has requested a trading halt on its ordinary shares and listed options on the ASX pending an announcement regarding a proposed capital raising. This trading halt is intended to assist the company in managing its continuous disclosure obligations and is expected to remain in place until the announcement is made or until normal trading resumes on 18 September 2025.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.52 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Neurizon Therapeutics Limited is a company listed on the Australian Securities Exchange (ASX) under the ticker NUZ. The company is involved in the biotechnology industry, focusing on the development of therapeutic solutions.
Average Trading Volume: 319,149
Technical Sentiment Signal: Sell
Current Market Cap: A$73.85M
Learn more about NUZ stock on TipRanks’ Stock Analysis page.